Literature DB >> 35278306

Differential T-Cell Immunity to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in mRNA-1273- and BNT162b2-Vaccinated Individuals.

Kathleen M E Gallagher1,2,3, Mark B Leick2,4, Rebecca C Larson2,4, Trisha R Berger2, Katelin Katsis1,2, Jennifer Y Yam1,2, Marcela V Maus2,4.   

Abstract

COVID-19 breakthrough cases among vaccinated individuals demonstrate the value of measuring long-term immunity to SARS-CoV-2 and its variants. We demonstrate that anti-spike T-cell responses and IgG antibody levels are maintained but decrease over time and are lower in BNT162b2- versus mRNA-1273-vaccinated individuals. T-cell responses to the variants are relatively unaffected.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  BNT162b2; SARS-CoV2 mRNA vaccine; T-cell immunity; T-cell response; mRNA-1273

Mesh:

Substances:

Year:  2022        PMID: 35278306      PMCID: PMC9402689          DOI: 10.1093/cid/ciac201

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   20.999


  12 in total

1.  mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant.

Authors:  Bezawit A Woldemeskel; Caroline C Garliss; Joel N Blankson
Journal:  Clin Infect Dis       Date:  2022-08-24       Impact factor: 20.999

2.  mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.

Authors:  Rishi R Goel; Mark M Painter; Sokratis A Apostolidis; Divij Mathew; Wenzhao Meng; Aaron M Rosenfeld; Kendall A Lundgreen; Arnold Reynaldi; David S Khoury; Ajinkya Pattekar; Sigrid Gouma; Leticia Kuri-Cervantes; Philip Hicks; Sarah Dysinger; Amanda Hicks; Harsh Sharma; Sarah Herring; Scott Korte; Amy E Baxter; Derek A Oldridge; Josephine R Giles; Madison E Weirick; Christopher M McAllister; Moses Awofolaju; Nicole Tanenbaum; Elizabeth M Drapeau; Jeanette Dougherty; Sherea Long; Kurt D'Andrea; Jacob T Hamilton; Maura McLaughlin; Justine C Williams; Sharon Adamski; Oliva Kuthuru; Ian Frank; Michael R Betts; Laura A Vella; Alba Grifoni; Daniela Weiskopf; Alessandro Sette; Scott E Hensley; Miles P Davenport; Paul Bates; Eline T Luning Prak; Allison R Greenplate; E John Wherry
Journal:  Science       Date:  2021-12-03       Impact factor: 63.714

3.  BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype.

Authors:  Gisella Guerrera; Mario Picozza; Silvia D'Orso; Roberta Placido; Marta Pirronello; Alice Verdiani; Andrea Termine; Carlo Fabrizio; Flavia Giannessi; Manolo Sambucci; Maria Pia Balice; Carlo Caltagirone; Antonino Salvia; Angelo Rossini; Luca Battistini; Giovanna Borsellino
Journal:  Sci Immunol       Date:  2021-12-24

4.  Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.

Authors:  Wilfredo F Garcia-Beltran; Evan C Lam; Kerri St Denis; Adam D Nitido; Zeidy H Garcia; Blake M Hauser; Jared Feldman; Maia N Pavlovic; David J Gregory; Mark C Poznansky; Alex Sigal; Aaron G Schmidt; A John Iafrate; Vivek Naranbhai; Alejandro B Balazs
Journal:  Cell       Date:  2021-03-12       Impact factor: 41.582

5.  mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.

Authors:  Wilfredo F Garcia-Beltran; Kerri J St Denis; Angelique Hoelzemer; Evan C Lam; Adam D Nitido; Maegan L Sheehan; Cristhian Berrios; Onosereme Ofoman; Christina C Chang; Blake M Hauser; Jared Feldman; Alex L Roederer; David J Gregory; Mark C Poznansky; Aaron G Schmidt; A John Iafrate; Vivek Naranbhai; Alejandro B Balazs
Journal:  Cell       Date:  2022-01-06       Impact factor: 41.582

6.  Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines.

Authors:  Ai-Ris Y Collier; Jingyou Yu; Katherine McMahan; Jinyan Liu; Abishek Chandrashekar; Jenny S Maron; Caroline Atyeo; David R Martinez; Jessica L Ansel; Ricardo Aguayo; Marjorie Rowe; Catherine Jacob-Dolan; Daniel Sellers; Julia Barrett; Kunza Ahmad; Tochi Anioke; Haley VanWyk; Sarah Gardner; Olivia Powers; Esther A Bondzie; Huahua Wan; Ralph S Baric; Galit Alter; Michele R Hacker; Dan H Barouch
Journal:  N Engl J Med       Date:  2021-10-15       Impact factor: 91.245

7.  Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.

Authors:  Mark G Thompson; Jefferey L Burgess; Allison L Naleway; Harmony Tyner; Sarang K Yoon; Jennifer Meece; Lauren E W Olsho; Alberto J Caban-Martinez; Ashley L Fowlkes; Karen Lutrick; Holly C Groom; Kayan Dunnigan; Marilyn J Odean; Kurt Hegmann; Elisha Stefanski; Laura J Edwards; Natasha Schaefer-Solle; Lauren Grant; Katherine Ellingson; Jennifer L Kuntz; Tnelda Zunie; Matthew S Thiese; Lynn Ivacic; Meredith G Wesley; Julie Mayo Lamberte; Xiaoxiao Sun; Michael E Smith; Andrew L Phillips; Kimberly D Groover; Young M Yoo; Joseph Gerald; Rachel T Brown; Meghan K Herring; Gregory Joseph; Shawn Beitel; Tyler C Morrill; Josephine Mak; Patrick Rivers; Brandon P Poe; Brian Lynch; Yingtao Zhou; Jing Zhang; Anna Kelleher; Yan Li; Monica Dickerson; Erika Hanson; Kyley Guenther; Suxiang Tong; Allen Bateman; Erik Reisdorf; John Barnes; Eduardo Azziz-Baumgartner; Danielle R Hunt; Melissa L Arvay; Preeta Kutty; Alicia M Fry; Manjusha Gaglani
Journal:  N Engl J Med       Date:  2021-06-30       Impact factor: 91.245

8.  SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees.

Authors:  Daryl Geers; Marc C Shamier; Rory D de Vries; Corine H GeurtsvanKessel; Susanne Bogers; Gerco den Hartog; Lennert Gommers; Nella N Nieuwkoop; Katharina S Schmitz; Laurine C Rijsbergen; Jolieke A T van Osch; Emma Dijkhuizen; Gaby Smits; Anouskha Comvalius; Djenolan van Mourik; Tom G Caniels; Marit J van Gils; Rogier W Sanders; Bas B Oude Munnink; Richard Molenkamp; Herbert J de Jager; Bart L Haagmans; Rik L de Swart; Marion P G Koopmans; Robert S van Binnendijk
Journal:  Sci Immunol       Date:  2021-05-25

9.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals.

Authors:  Alison Tarke; John Sidney; Nils Methot; Esther Dawen Yu; Yun Zhang; Jennifer M Dan; Benjamin Goodwin; Paul Rubiro; Aaron Sutherland; Eric Wang; April Frazier; Sydney I Ramirez; Stephen A Rawlings; Davey M Smith; Ricardo da Silva Antunes; Bjoern Peters; Richard H Scheuermann; Daniela Weiskopf; Shane Crotty; Alba Grifoni; Alessandro Sette
Journal:  Cell Rep Med       Date:  2021-07-02
View more
  2 in total

1.  Cellular and Humoral Responses Follow-up for 8 Months after Vaccination with mRNA-Based Anti-SARS-CoV-2 Vaccines.

Authors:  Sergio Gil-Manso; Diego Carbonell; Verónica Astrid Pérez-Fernández; Rocío López-Esteban; Roberto Alonso; Patricia Muñoz; Jordi Ochando; Ignacio Sánchez-Arcilla; Jose M Bellón; Rafael Correa-Rocha; Marjorie Pion
Journal:  Biomedicines       Date:  2022-07-12

2.  GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine.

Authors:  Ieva Čiučiulkaitė; Birte Möhlendick; Laura Thümmler; Neslinur Fisenkci; Carina Elsner; Ulf Dittmer; Winfried Siffert; Monika Lindemann
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.